Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry.

Ilya TsimafeyeuOxana ShatkovskayaSergei KrasnyNurzhan NurgalievIlya VarlamovVladislav PetkauSufia SafinaRuslan ZukovMikhail MazhbichGalina StatsenkoSergey VarlamovOlga NovikovaIgor ZaitsevPavel MoiseyevAlexander RolevichAlesya EvmenenkoIrina PopovaDilyara KaidarovaLiubov Vladimirova

Published in: Cancer reports (Hoboken, N.J.) (2020)

Half of patients received no systemic therapy or had only cytokines for mRCC in Russia, Kazakhstan, and Belarus, which doubtless negatively affected OS in this population. Novel therapies should be considered as life prolonging and a priority.

Keyphrases

metastatic renal cell carcinoma
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
patient reported outcomes
bone marrow
free survival
cell therapy
smoking cessation